**Abstract**

Valproic acid (VPA) is a drug commonly used as an antiepileptic and mood stabilizer. We describe a patient who presented with particularly severe, but reversible parkinsonism during VPA treatment. We also provide a literature review on VPA-induced parkinsonism. The case was a 75-year-old woman who was diagnosed with bipolar disorder and was stabilized on lithium since the age of 50. At the age of 74, she started complaining of freezing of gait, which did not improve with L-DOPA administration. She became depressed and was admitted to a psychiatric ward. The patient complained of finger tremors, which improved after lithium was switched to 1000-mg/day VPA. The change in medication ameliorated both the tremors and the depressive symptoms. She was discharged from the hospital after 2 months. However, her parkinsonism worsened 4 months after discharge. The subsequent exacerbation of parkinsonism left her bedridden and unable to walk by herself. Her Unified Parkinson†s Disease Rating Scale score was 98. Because drug-induced parkinsonism was suspected, VPA was gradually withdrawn thereafter. Forty-five days later, she was able to walk by herself with a cane. The Unified Parkinson†s Disease Rating Scale score improved to 11. Improvement of parkinsonism after withdrawal of the medication led us to diagnose her as age-related vascular parkinsonism exacerbated by medication. Previous studies showed that approximately 20% of patients on chronic VPA therapy developed tremor (Aleksandar J et al., 2006). In majority of the previously reported VPA-induced parkinsonism cases, the parkinsonism was improved after discontinuation of the drug (Mahmoud F et al., 2011). Although drug-induced parkinsonism is a frequent side-effect of VPA, severe cases such as the present case are uncommon. The recognition of VPA-induced parkinsonism is of great clinical significance, because appropriate treatment results in significant improvement of symptoms.
